Louise Benarroch1, Chantel Kowalchuk1,2, Virginia Wilson1, Celine Teo1, Melanie Guenette1, Araba Chintoh1,3, Yasika Nesarajah1, Valerie Taylor1,3,4, Peter Selby1,5,6, Paul Fletcher1,7, Gary J Remington8,9,10, Margaret K Hahn11,12,13. 1. Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. 2. Institute of Medical Sciences, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. 3. Department of Psychiatry, University of Toronto, 250 College Street, Toronto, ON, M5T 1R8, Canada. 4. Women's College Research Institute, 7th Floor, 790 Bay St, Toronto, ON, M5G 1N8, Canada. 5. Department of Family and Community Medicine, University of Toronto, 500 University Ave, Toronto, ON, M5G 1V7, Canada. 6. Dalla Lana School of Public Health, University of Toronto, 155 College St, Toronto, ON, M5T 3M7, Canada. 7. Department of Psychology, University of Toronto, 100 St. George Street, Toronto, ON, M5S 3G3, Canada. 8. Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. gary.remington@utoronto.ca. 9. Institute of Medical Sciences, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. gary.remington@utoronto.ca. 10. Department of Psychiatry, University of Toronto, 250 College Street, Toronto, ON, M5T 1R8, Canada. gary.remington@utoronto.ca. 11. Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada. maggie.hahn@utoronto.ca. 12. Institute of Medical Sciences, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8, Canada. maggie.hahn@utoronto.ca. 13. Department of Psychiatry, University of Toronto, 250 College Street, Toronto, ON, M5T 1R8, Canada. maggie.hahn@utoronto.ca.
Abstract
RATIONALE: So-called atypical antipsychotics (AAPs) are associated with varying levels of weight gain and associated metabolic disturbances, which in patients with serious mental illness (SMI) have been linked to non-compliance and poor functional outcomes. Mechanisms underlying AAP-induced metabolic abnormalities are only partially understood. Antipsychotic-induced weight gain may occur as a result of increases in food intake and/or changes in feeding. OBJECTIVE: In this review, we examine the available human and preclinical literature addressing AAP-related changes in feeding behavior, to determine whether changes in appetite and perturbations in regulation of food intake could be contributing factors to antipsychotic-induced weight gain. RESULTS: In general, human studies point to disruption by AAPs of feeding behaviors and food consumption. In rodents, increases in cumulative food intake are mainly observed in females; however, changes in feeding microstructure or motivational aspects of food intake appear to occur independent of sex. CONCLUSIONS: The findings from this review indicate that the varying levels of AAP-related weight gain reflect changes in both appetite and feeding behaviors, which differ by type of AAP. However, inconsistencies exist among the studies (both human and rodent) that may reflect considerable differences in study design and methodology. Future studies examining underlying mechanisms of antipsychotic-induced weight gain are recommended in order to develop strategies addressing the serious metabolic side effect of AAPs.
RATIONALE: So-called atypical antipsychotics (AAPs) are associated with varying levels of weight gain and associated metabolic disturbances, which in patients with serious mental illness (SMI) have been linked to non-compliance and poor functional outcomes. Mechanisms underlying AAP-induced metabolic abnormalities are only partially understood. Antipsychotic-induced weight gain may occur as a result of increases in food intake and/or changes in feeding. OBJECTIVE: In this review, we examine the available human and preclinical literature addressing AAP-related changes in feeding behavior, to determine whether changes in appetite and perturbations in regulation of food intake could be contributing factors to antipsychotic-induced weight gain. RESULTS: In general, human studies point to disruption by AAPs of feeding behaviors and food consumption. In rodents, increases in cumulative food intake are mainly observed in females; however, changes in feeding microstructure or motivational aspects of food intake appear to occur independent of sex. CONCLUSIONS: The findings from this review indicate that the varying levels of AAP-related weight gain reflect changes in both appetite and feeding behaviors, which differ by type of AAP. However, inconsistencies exist among the studies (both human and rodent) that may reflect considerable differences in study design and methodology. Future studies examining underlying mechanisms of antipsychotic-induced weight gain are recommended in order to develop strategies addressing the serious metabolic side effect of AAPs.
Authors: U Eder; B Mangweth; C Ebenbichler; E Weiss; A Hofer; M Hummer; G Kemmler; M Lechleitner; W W Fleischhacker Journal: Am J Psychiatry Date: 2001-10 Impact factor: 18.112
Authors: W Wolfgang Fleischhacker; Martti E Heikkinen; Jean-Pierre Olié; Wally Landsberg; Patricia Dewaele; Robert D McQuade; Jean-Yves Loze; Delphine Hennicken; Wendy Kerselaers Journal: Int J Neuropsychopharmacol Date: 2010-05-12 Impact factor: 5.176
Authors: Trino Baptista; Emma Araujo de Baptista; Josee Lalonde; Julie Plamondon; N M K Ng Ying Kin; Serge Beaulieu; Rhida Joober; Denis Richard Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2004-12 Impact factor: 5.067
Authors: M J Fell; N Anjum; K Dickinson; K M Marshall; L M Peltola; S Vickers; S Cheetham; J C Neill Journal: Psychopharmacology (Berl) Date: 2007-06-21 Impact factor: 4.415
Authors: S Kanji; T M Fonseka; V S Marshe; V Sriretnakumar; M K Hahn; D J Müller Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-06-17 Impact factor: 5.270
Authors: Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg Journal: Behav Brain Res Date: 2021-01-14 Impact factor: 3.332
Authors: Alex T Raben; Victoria S Marshe; Araba Chintoh; Ilona Gorbovskaya; Daniel J Müller; Margaret K Hahn Journal: Front Neurosci Date: 2018-01-22 Impact factor: 4.677
Authors: Adriano Aquino; Guilherme L Alexandrino; Paul C Guest; Fabio Augusto; Alexandre F Gomes; Michael Murgu; Johann Steiner; Daniel Martins-de-Souza Journal: Front Psychiatry Date: 2018-05-25 Impact factor: 4.157